On March 16, Massachusetts General Hospital (MGH) achieved another medical milestone by performing the first successful pig-to-human kidney transplant.
Using a genetically modified organ made by Massachusetts-based biotech eGenesis, Rick Slayman, a 62-year-old patient with end-stage kidney disease, underwent a four-hour xenotransplantation surgery, or the transfer of organs in a human from nonhuman sources, the hospital announced in a statement.
With more than 100,000 people in the US on waitlists, experts said the success of the procedure laid grounds for optimism of more similar organ transplants.
But on May 7, Slayman died. He was facing cardiovascular issues, which ended his life only 51 days after the groundbreaking procedure. At the end of May, Healthcare Brew spoke with two experts involved with the transplant about the implications of Slayman’s death on the future of this kind of xenotransplantation.
Keep reading here.—CM
|